gBETA Medtech Program Returns

gBETA Medtech Program Returns

The seven-week program is designed to prepare companies to compete in a full-time, equity-based accelerator.

After a year hiatus, startup accelerator gener8tor and University Enterprise Laboratories are bringing back the gBETA Medtech program.

The seven-week program provides coaching and mentorship for startups building medical devices, healthcare software, and other related tech. Five startups will participate in the 2020 round, and all but one are from the Twin Cities metro:

  • Anatomi Corp., a U of M startup that has developed a technique for building human neurons in a week. The company was recently recognized on TCB’s Tech 20 list.
  • Laplace Interventional, which has built a device to treat a condition known as “tricuspid regurgitation,” which can lead to right-side heart failure.
  • Pleasanton, California-based Sandstone Diagnostics, maker of the Torq system, a handheld centrifuge device for lab tests.
  • StimSherpa, which has crafted a platform to help people with spinal cord injuries.
  • Visana Health, which has built a digital health platform to help women suffering from endometriosis.

“One of the main goals of gBETA is to provide the resources and networks these startups need to succeed,” said Jackie Mejia, who has been named director of the program. 

To participate, teams must be physically present in Minneapolis. (“It’s not a virtual program,” Mejia said.) Companies don’t need to sacrifice any equity or pay fees to take part in the program, she noted. By the end of the program, though, participants will be primed to apply for equity-based accelerators or seed investments.

This year’s sponsors include Boston Scientific, Mayo Clinic, the University of Minnesota, and the Medical Alley Association.

gener8tor, which formed in Wisconsin but set up an arm in Minnesota in 2016, held a kickoff event for the program on Feb. 13

The gBETA program first launched in 2018, with three cohorts comprising 18 companies.